Barely Significant
← all excerpts

Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry.

Front Neurol · 2021 · PMC8248666 · PMID 34220694

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp < 0.001actually significant
The difference in the proportion of patients achieving NEDA on high efficacy drugs and the odds ratio of achieving NEDA were lower for the second drug, but still highly significant ( p < 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.